Encompass Health Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Encompass Health Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Encompass Health Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $93.4M, a 16.6% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $93.4M +$13.3M +16.6% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $80.1M -$300K -0.37% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $80.4M -$46.7M -36.7% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $127M -$46.5M -26.8% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $174M +$26.8M +18.3% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $22.4M -$60.2M -72.9% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $42.6M -$32.8M -43.5% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $40.5M -$28M -40.9% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $147M -$8.1M -5.23% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $82.6M -$9M -9.83% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $75.4M -$26.7M -26.2% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $68.5M +$33.2M +94.1% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $155M -$73.8M -32.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $91.6M +$19M +26.2% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $102M -$13.4M -11.6% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $35.3M -$110M -75.7% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $229M -$111M -32.6% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $72.6M -$169M -69.9% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $116M -$153M -56.9% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $145M -$146M -50.1% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $339M -$113M -25% Dec 31, 2015 8-K 2017-09-19
Q3 2015 $241M -$153M -38.8% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $268M -$147M -35.4% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $291M -$174M -37.4% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $453M -$101M -18.3% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $394M -$156M -28.3% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $415M -$167M -28.7% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 $464M -$33.1M -6.66% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $554M -$4M -0.72% Dec 31, 2013 10-K 2015-03-02
Q3 2013 $550M -$3M -0.54% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $582M +$3M +0.52% Jun 30, 2013 10-Q 2013-07-30
Q1 2013 $497M -$109M -18% Mar 31, 2013 10-Q 2013-04-26
Q4 2012 $558M -$97.7M -14.9% Dec 31, 2012 10-K 2014-02-20
Q3 2012 $553M -$96.5M -14.9% Sep 30, 2012 10-Q 2012-10-26
Q2 2012 $579M -$111M -16.1% Jun 30, 2012 10-Q 2012-07-27
Q1 2012 $606M Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $656M -$52.1M -7.36% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $650M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $691M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $708M Dec 31, 2010 8-K 2012-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.